This cancer lacks immunohistochemical expression of the estrogen receptor (ER) and progesterone receptor (PR) and does not overexpress human epidermal growth factor receptor 2 (HER2) immunohistochemically or in situ hybridization [2, 3]. The gene discussed is ERBB2; the disease is cancer.